Kit for visually detecting IHHNV based on CRISPR / Cas12a

Through the CRISPR/Cas12a visual detection method, combined with specific RAA primers and crRNA sequences, an IHHNV rapid detection kit suitable for shrimp farming was developed, which solved the problem of expensive equipment and professional dependence in the prior art, and realized the IHHNV Efficient and simple on-site inspection, suitable for rapid screening of ports and farms.

CN119061199APending Publication Date: 2024-12-03湛江海关技术中心
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411115801.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The conventional PCR and fluorescent PCR methods used in shrimp farming for IHHNV detection require expensive equipment and professionals, and are not suitable for rapid on-site testing, making it difficult to meet the needs of rapid customs clearance and on-site screening.

Method used

Using the visual detection method based on CRISPR/Cas12a, by designing specific RAA primers and crRNA sequences, combining fluorescence detection and immunocolloid gold strip detection, IHHNV CRISPR/Cas12a visual detection kit is developed, which achieves ease of operation and no equipment. Relying on fast detection.

Benefits of technology

It realizes high specificity and sensitivity detection of IHHNV, is suitable for rapid on-site screening of ports and farms, reduces detection costs and technical requirements, and is of great significance to the prevention and control of IHHNV for imported and exported shrimps.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061199A_ABST
    Figure CN119061199A_ABST
Patent Text Reader

Abstract

The invention discloses a CRISPR (clustered regularly interspaced short palindromic repeats) / Cas12a (clustered regularly interspaced short palindromic repeats)-based IHHNV (infectious hematopoietic necrosis virus) visual detection kit, which is used for combining RAA (recombinase of association) with CRISPR / Cas12a and comprises an RAA primer and a crRNA (complementary ribosomal ribonucleic acid) sequence; the invention discloses a method for visually detecting IHHNV based on CRISPR / Cas 12a, which comprises the following steps of: amplifying a target fragment under the condition of 37 DEG C, and reading a result through fluorescence signal detection or colloidal gold lateral flow test strip. The invention further discloses a kit for visually detecting the IHHNV based on the CRISPR / Cas 12a and application of a detection method, the kit does not depend on precise instruments, is good in specificity and high in sensitivity, and achieves rapid on-site detection of the prawn IHHNV under the condition that experimental conditions such as farms and ports are relatively simple.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biological detection technology, and specifically to a kit for visually detecting infectious subcutaneous and hematopoietic necrosis viruses based on CRISPR / Cas12a, and specifically to a sequence combination, a detection kit, a detection method and an application thereof for detecting infectious subcutaneous and hematopoietic necrosis viruses based on CRISPR / Cas12a. Background Art

[0002] Infectious hypodermal and haematopoietic necrosis virus (IHHNV) is one of the most common diseases in shrimp farming. It was first discovered in Penaeus stylirostris in Hawaii, USA in 1981 [Lightner, 1983], and was subsequently detected in many crustacean and non-crustacean species. It is widely prevalent in shrimp farming areas in Asia, Oceania, North America, South America and the Middle East. It is listed as a notifiable crustacean disease by the World Organization for Animal Health (WOAH). IHHNV is the smallest known shrimp virus, with a diameter of 20-22nm, a non-enveloped icosahedron, and a length of about 4.1kb linear single-stranded DNA. The effects of IHHNV infection are acute and chronic, depending on the shrimp species. Infection with IHHNV in Penaeus stylirostris can cause acute death, with a mortality rate close to 100%. However, Penaeus vannamei and Penaeus monodon cause a chronic disease, namely Runt deformity syndrome (RDS), which does not cause high mortality, but has symptoms of growth inhibition and cuticle deformity [Sellars, 2019; Kalagayan, 1991].

[0003] The scale of aquaculture in my country is constantly expanding, and the intensive farming model is developing rapidly. The situation of aquaculture diseases has become very serious. IHHNV, as a viral disease, is one of the main diseases in shrimp farming. However, the disease is currently mainly detected by ordinary PCR and fluorescent PCR. Although they have strong specificity and high sensitivity, the instruments are expensive, require special experimental sites, and have high requirements for detection personnel.

[0004] Recombinase-mediated isothermal amplification (RAA) combined with CRISPR-Cas12a is an emerging nucleic acid detection technology that can be visualized. In the context of rapid customs clearance, it is suitable for rapid on-site detection. Therefore, a CRISPR / Cas12a visualization detection kit for IHHNV was developed and applied to the rapid detection of IHHNV in shrimp at ports and farms. Summary of the invention

[0005] In the first aspect, the present invention provides a sequence combination for visual detection of IHHNV based on CRIPR / Cas12a, including a RAA primer and a crRNA sequence specific for constant temperature amplification of IHHNV; the RAA upstream primer specific for constant temperature amplification of IHHNV is IHHNV F2, the nucleotide sequence is shown in SEQ ID NO: 3, and the RAA downstream primer specific for constant temperature amplification of IHHNV is IHHNV-RAA-R1, the nucleotide sequence is shown in SEQ ID NO: 4; the nucleotide sequence of crRNA for IHHNV is shown in SEQ ID NO: 6;

[0006] Furthermore, the sequence combination also includes a reporter probe sequence; the reporter probe sequence is a single-stranded DNA reporter probe sequence for fluorescence detection or a single-stranded DNA reporter probe sequence for immunocolloidal gold test strip detection;

[0007] Among them, the single-stranded DNA reporter probe sequence used for fluorescence detection, the specific nucleotide sequence P1 is 5, -FAM-TTATT-BHQ1 -3;

[0008] The single-stranded DNA reporter probe sequence used for immune colloidal gold test strip detection, the specific nucleotide sequence P2 is 5, -FAM-TTTTTTTTTTTTTTTTTTTT-BIOTIN-3.

[0009] In a second aspect, the present invention also provides a kit for visual detection of IHHNV based on CRISPR / Cas 12a, wherein the kit comprises RAA primers and crRNA sequences and a single-stranded DNA reporter probe sequence specific for isothermal amplification of IHHNV.

[0010] The kit includes reaction reagents for RAA amplification reaction and reagents for performing CRISPR / Cas 12a reaction.

[0011] The total volume of the reaction reagents for RAA amplification is 50uL, and the reaction reagents include dry powder enzyme preparation, water, RAA upstream primer IHHNV F2 / R1, RAA downstream primer IHHNV-RAA-R1, A Buffer, B Buffer and DNA nucleic acid to be detected.

[0012] The total volume of the reagents for performing the CRISPR / Cas 12a reaction is 50uL, and the reaction reagents include reagents for the CRISPR / Cas 12a reaction for fluorescence detection and reagents for the CRISPR / Cas 12a reaction for immunocolloidal gold test strip detection.

[0013] The reagents for the CRISPR / Cas 12a reaction for fluorescence detection include Cas12a enzyme, IHHNV-crRNA, reaction buffer, single-stranded DNA reporter probe-P1 for fluorescence detection, ddH2O, and specific RAA products to be detected.

[0014] The reagents for the CRISPR / Cas 12a reaction for immunocolloidal gold test strip detection include Cas12a enzyme, IHHNV-crRNA, reaction buffer, single-stranded DNA reporter probe-P2 for immunocolloidal gold test strip detection, ddH2O, and specific RAA products to be detected.

[0015] In a third aspect, the present invention provides a method for detecting IHHNV based on CRISPR / Cas 12a visualization, comprising the following steps:

[0016] Step 1): Sample processing: take the shrimp muscle tissue, cut it into pieces and centrifuge it;

[0017] Step 2): Extracting nucleic acid from shrimp muscle tissue;

[0018] Step 3): RAA amplification reaction;

[0019] Step 4): Using the above-mentioned kit, take the RAA amplification primer for CRISPR / Cas 12a reaction reagent for fluorescence detection or immunocolloidal gold test strip detection.

[0020] Further, in step 1), about 50 mg of shrimp muscle tissue was taken, chopped with scissors and placed in a 2 mL centrifuge tube, steel beads and 1 mL 1 mol / L PBS were added, and after shaking with a homogenizer, centrifuged at 12000 rpm for 2 min, and the supernatant was used for nucleic acid extraction.

[0021] In step 2), nucleic acid extraction was performed using an ABI commercial kit, genomic DNA was extracted according to the instructions, and the extracted nucleic acid was used as a template for RAA amplification.

[0022] In step 3), the total volume of the amplification reaction reagents is 50 uL. First, add 25 μL of A Buffer, 2 uL of RAA upstream primer IHHNV F2 / R1, 2 uL of RAA downstream primer IHHNV-RAA-R1, and 13.5 uL of water to the detection unit tube containing the dry powder enzyme preparation, and then add 5 uL of the DNA nucleic acid to be tested to the detection unit tube; add 2.5 uL of B Buffer to the detection unit tube cap, cover the tube cap, turn it upside down and shake it gently to mix it thoroughly, and then centrifuge it at low speed for 10 sec;

[0023] The centrifuged detection unit tube was placed in a 39°C constant temperature metal bath or water bath and incubated for 30 minutes.

[0024] The total volume of reagents used for CRISPR / Cas 12a reaction in step 4) is 50uL; the reaction reagents are selected from any of the following:

[0025] The reagents used for CRISPR / Cas 12a fluorescence detection reaction include: adding Cas12a enzyme 0.5 μL, IHHNV-crRNA 0.2uL, 10× reaction buffer 5 μL, single-stranded DNA reporter probe for fluorescence detection--P12uL, ddH2O 40.3 uL, and specific RAA product to be detected 2uL into a PCR tube, cover the tube, vortex evenly, and then centrifuge at low speed for 10 s;

[0026] The fluorescence PCR instrument was set to a reaction temperature of 37°C and the fluorescence value was read every 1 min for 45 min.

[0027] The reagents for the CRISPR / Cas 12a reaction for immunocolloidal gold test strip detection include: adding Cas12a (2 μM) 0.5 μL and IHHNV-crRNA 0.2 μL, 10× reaction buffer 5 μL, single-stranded DNA reporter probe-P22 uL of colloidal gold test strip, ddH2O4 0.3 uL, and specific RAA product to be detected 2 uL in a PCR tube, capping the tube, vortexing evenly, and then centrifuging at low speed for 10 s;

[0028] The reaction tube was incubated at 37°C for 30 min. After the incubation, a colloidal gold test strip was added to read the result.

[0029] In a fourth aspect, the present invention provides an application of a detection method for visually detecting IHHNV based on CRISPR / Cas 12a in IHHNV detection.

[0030] Compared with the prior art, the present invention has at least the following beneficial effects:

[0031] Traditional fluorescent PCR and ordinary PCR generally require expensive detection equipment, standardized conditions and professional detection personnel. The kit of the present invention has good specificity and high sensitivity. The RAA-mediated CRIPR / Cas12a detection method of IHHNV of the present invention is easy to operate, does not rely on sophisticated laboratory equipment, and can read the test results by fluorescent equipment or immune colloidal gold lateral flow test strips. Under the background of rapid customs clearance, it can be efficiently used for on-site screening of IHHNV in shrimps at ports, farms, etc., which is of great significance for the prevention and control of IHHNV in imported and exported shrimps. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 This is the electrophoresis result of RAA primer screening of IHHNV;

[0033] FIG. 2 is a diagram of Cas12a protein concentration screening of the present invention;

[0034] in Figure 2A It is a fluorescence value curve diagram produced by different Cas12a protein concentrations of the present invention, Figure 2B This is a graph of the test results of lateral flow chromatography strips with different Cas12a protein concentrations;

[0035] Figure 3 is a crRNA concentration screening diagram;

[0036] in Figure 3A This is a graph of fluorescence values ​​produced by different crRNA concentrations. Figure 3B This is a graph of the test results of lateral flow chromatography strips with different crRNA concentrations;

[0037] FIG4 is a diagram of the reporter probe concentration screening of the present invention;

[0038] in Figure 4A It is a fluorescence curve graph produced by different reporter probe concentrations. Figure 4B This is a graph of the test results of lateral flow chromatography test strips with different reporter probe concentrations;

[0039] FIG5 is a specificity test diagram of CRISPR / Cas12a detection reagent;

[0040] in Figure 5A It is a curve diagram of the fluorescence value of the present invention for detecting IHHNV and other common diseases of aquatic animals. Figure 5B It is a graph showing the test results of the lateral flow chromatography test strips for IHHNV and other common diseases of aquatic animals of the present invention;

[0041] FIG6 is a sensitivity test diagram of CRISPR / Cas12a detection reagent;

[0042] in Fig. 6A is a fluorescence value curve diagram of the pUC57-PVA1 plasmid of the present invention at different dilution ratios. Figure 6B It is a graph showing the detection results of the lateral flow chromatography test strip under different dilution ratios of the pUC57-PVA1 plasmid copy number of the present invention. DETAILED DESCRIPTION

[0043] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described implementation is only a part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0044] In the following examples, RAA nucleic acid amplification reagent (basic type) was purchased from Hangzhou Zhongce Biotechnology Co., Ltd.; Cas12a protein was purchased from Guangzhou Meige Biotechnology Co., Ltd.; and CRISPR single system detection test strips were purchased from Tolo Biotechnology Co., Ltd.

[0045] The primers, probes and plasmids in the following examples were all commissioned to be synthesized by Huzhou Hippo Biotechnology Co., Ltd.

[0046] In the following examples, the IHHNV gene-positive plasmid was cloned in the pUC57 vector.

[0047] Example 1 Establishment of CRISPR / Cas12a Visualization Detection Kit for IHHNV

[0048] The present embodiment provides a CRISPR / Cas12a visualization rapid detection kit for IHHNV, which includes a recombinase-mediated RAA amplification method and a CRISPR / Cas 12a detection method, wherein the recombinase-mediated RAA amplification method includes IHHNV isothermal amplification-specific RAA primers, RAA amplification reagents and amplification procedures; the CRISPR / Cas12a detection method includes IHHNV-specific crRNA, a reporter probe, reaction reagents and reaction procedures for a fluorescence detection method, and reaction reagents and reaction procedures for a colloidal gold test strip method.

[0049] 1. Design of RAA Primers for IHHNV

[0050] DNASTAR software was used for homology analysis and Blast sequence analysis, and the conserved sequence of the nonstructural protein of IHHNV was screened out as follows: GTCAGGGCGAACCAGAATCACTTAGTGAATTGCTTCGAGAACGCACGAACGAAACTCACTCCAGCCAGGGAATTTCTCCAAGCCTTCTCACCCCAGGTCCAAATCAAGACCCTAAACCCACTACCGAAC (SEQ ID NO: 1);

[0051] The highly conserved sequence of 129 bp obtained by screening was used as the gene fragment for detection, and primers were designed for screening and detection.

[0052] According to the IHHNV conserved sequence, the upstream primer and downstream primer sequences are as follows:

[0053] F1: 5 , - CAGAATCACTTAGTGAATTGCTTCGAGAAC -3 , (SEQ ID NO:2);

[0054] F2: 5 , -GTCAGGGCGAACCAGAATCACTTAGTGAAT -3 , (SEQ ID NO:3);

[0055] R1: 5 , -GTAGTGGGTTTAGGGTCTTGATTTGGACCT -3 , (SEQ ID NO:4);

[0056] R2: 5 , -GTTCGGTAGTGGGTTTAGGGTCTTGATTTG -3 , (SEQ ID NO:5) .

[0057] The above primers were combined into 4 primer combinations as shown in Table 1.

[0058] Table 1: IHHNV-specific RAA primer sequence information

[0059]

[0060] 2. Screening of RAA Primers for IHHNV

[0061] RAA nucleic acid amplification reagent was used to screen four primer combinations of IHHNV (Table 1). IHHNV nucleic acid was used as a template to prepare RAA amplification reagent. The amplification reagent was 50uL: a. First, add 25μL ABuffer, 2μL IHHNV upstream primer F2 (10 μM), 2μL IHHNV downstream primer R1 (10 μM), and 13.5uL water to the detection unit tube containing the dry powder enzyme preparation; b. Then add 5uL of DNA nucleic acid to be tested to the detection unit tube; c. Add 2.5uL of B Buffer to the detection unit tube cap, cover the tube cap, turn it upside down and shake it gently to mix thoroughly, and then centrifuge it at low speed for 10 sec. RAA reaction procedure: The detection unit tube is placed in a 39℃ constant temperature metal bath or water bath and incubated for 30min.

[0062] After the product was purified, the bands were observed by PCR electrophoresis. The results showed that the electrophoresis bands of the third group F2 / R1 were brighter ( Figure 1), the product concentration is higher, so the preferred RAA primer is F2 / R1, specifically:

[0063] F2: 5 , -GTCAGGGCGAACCAGAATCACTTAGTGAAT -3 , (SEQ ID NO:3);

[0064] R1: 5 , -GTAGTGGGTTTAGGGTCTTGATTTGGACCT -3 , (SEQ ID NO:4).

[0065] 3. Establishment of CRISPR / Cas12a detection method

[0066] (1) Design of crRNA

[0067] Geneious v4.8.5 software was used to analyze the RAA amplified sequence to find the potential PAM (protospacer adjacent motif) sequence TTTN for CRISPR / Cas12a cleavage reaction, and the corresponding crRNA sequence was designed as follows:

[0068] IHHNV-crRNA: 5, -UAAUUUCUACUAAGUGUAGAUUCCAAGCCCUCUCACCCCAGGU -3, (SEQ ID NO: 6).

[0069] Fluorescence detection of single-stranded DNA reporter probe-P1 5,-FAM-TTATT-BHQ1-3,;

[0070] Colloidal gold test strip single-stranded DNA reporter probe-P2: 5,-FAM-TTTTTTTTTTTTTTTTTTTT-BIOTIN-3,

[0071] (2) Optimization of CRISP / Cas12a reaction reagents

[0072] The concentrations of crRNA, Cas12a protein and reporter probe were optimized. The concentrations of Cas12 protein were (12, 20, 30, 40, 50 nM), the concentrations of crRNA were (10, 20, 30, 40, 50 nM), and the concentrations of reporter probe were (100, 200, 400 nM). The optimal reaction concentration was determined by detecting the change in fluorescence value. The results are shown in Figure 2A -B. Figure 3A -B. Figure 4A-B, when the crRNA concentration is 40nM, the Cas12a concentration is 20nM, and the reporter probe concentration is 400nM, the fluorescence value is higher, so it is determined that when the crRNA concentration is 40nM, the Cas12a concentration is 20nM, and the reporter probe concentration is 400nM.

[0073] Example 2 CRISPR / Cas12a Visualization Detection Method Test of IHHNV

[0074] (1) Sample processing: Take about 50 mg of shrimp muscle tissue, chop it with scissors and place it in a 2 mL centrifuge tube. Add steel beads and 1 mL of 1 mol / L PBS. After shaking with a homogenizer, centrifuge at 12000 rpm for 2 min. The supernatant is used for nucleic acid extraction.

[0075] (2) Nucleic acid extraction: ABI commercial kit was used for nucleic acid extraction. Genomic DNA was extracted according to the instructions and the extracted nucleic acid was used as a template for RAA amplification.

[0076] (3) Preparation of RAA reaction reagent: see Table 2

[0077] Table 2: Preparation of RAA reaction reagents

[0078]

[0079] Reaction program: ABI fluorescent PCR instrument was used to set the parameters, the FAM channel was selected as the fluorescent channel, the quenching group was None, and the reaction program was 39°C 60 sec; 39°C 30 sec, 40 cycles.

[0080] (4) Reaction reagents and reaction procedures for CRISPR / Cas 12a fluorescence detection method:

[0081] a. The reaction reagent for the fluorescence detection method is 50 μL. Add Cas12a (2 μM) 0.5 μL, IHHNV-crRNA (10 μM) 0.2 μL, 10× reaction Buffer 5 μL, fluorescence detection reporter probe-P1 (10 uM) 2 uL, ddH2O 40.3 uL, and specific RAA product to be detected 2 uL into the PCR tube. Cover the tube, vortex evenly, and then centrifuge at low speed for 10 s.

[0082] b. Fluorescence detection reaction procedure: fluorescence PCR instrument, reaction temperature 37°C, read the fluorescence value every 1 minute, time is 45 minutes.

[0083] (5) Reagents and reaction procedures for CRISPR / Cas12a colloidal gold test strip method:

[0084] a. The reaction reagent of the colloidal gold test strip method is 50 μL. Add Cas12a (2 μM) 0.5 μL, IHHNV-crRNA (10 μM) 0.2uL, 10× reaction Buffer 5 μL, colloidal gold test strip reporter probe-P2 (10uM) 2uL, ddH2O 40.3uL, and specific RAA product to be detected 2uL into the PCR tube, cover the tube, vortex evenly, and then centrifuge at low speed for 10S.

[0085] b. Colloidal gold test strip method reaction procedure: Incubate the reaction tube at 37°C for 30 min; after incubation, add the colloidal gold test strip and read the result.

[0086] Example 3 Specificity test of the kit of the present invention

[0087] In order to detect the specificity of the kit of the present invention, the detection method in Example 2 was used to detect positive samples of common shrimp diseases white spot syndrome virus (WSSV), acute hepatopancreatic necrosis disease (AHPND), bacterial hepatopancreatitis (NHPB), enterocytosis (EHP), decapod iridovirus type I (DIV1), and yellow head virus type 1 infection (YHV-1) (where YHV-1 is reverse transcribed cDNA and the others are DNA samples), and the detection of IHHNV and other common diseases of aquatic animals by the kit was analyzed.

[0088] The test results showed that only the IHHNV positive samples showed normal amplification, while the positive samples of WSSV, AHPND, NHPB, EHP, DIV1, and YHV-1 did not show amplification (Figure 5). The above results show that the present invention can specifically amplify the target sequence fragment of IHHNV without cross-reacting with other bacteria, parasites, and viral nucleic acids, and the kit of the present invention has good specificity.

[0089] Example 4 Sensitivity test of the kit of the present invention

[0090] (1) Prepare pUC57-IHHNV standard solution and calculate the copy number based on the pUC57-IHHNV plasmid. The starting copy number of the pUC57-PVA1 plasmid is 6.4×10 10 copies / μL, and the plasmid was diluted 10-fold, taking 6.4×10 6 copy / uL, 6.4×10 5 copy / uL, 6.4×10 4 copy / uL, 6.4×10 3 copy / uL, 6.4×10 2 copy / uL, 6.4×10 1copy / uL, 6.4 copy / uL concentration standard samples were used as templates;

[0091] (2) Using 6.4×10 6 The 2000 copies / μL ~6.4 copies / μL standard was used as a template for amplification, and the reagents were configured and the reaction program was set according to the reaction reagents in the kit.

[0092] (3) The detection results are shown in FIG6 . The IHHNV of the kit still has a detection signal at 64 copies / μL, indicating that the kit of the present invention has high sensitivity.

[0093] Example 5 Application of the kit of the present invention in clinical samples

[0094] 121 retained imported frozen Penaeus vannamei tissue samples were tested using the kit of the present invention and a conventional fluorescent quantitative PCR method.

[0095] The test results showed that the RAA-AHPND test method detected 23 positive samples and 69 negative samples, which was consistent with the results of the conventional fluorescence quantitative PCR method. The positive coincidence rate of the two methods was 100%.

[0096] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A sequence combination for visual detection of IHHNV based on CRISPR / Cas 12a, It is characterized in that Includes RAA primers and crRNA sequences specific for constant temperature amplification of IHHNV; The RAA upstream primer specific for IHHNV isothermal amplification is IHHNV F2, and the nucleotide sequence is shown in SEQ ID NO: 3; The RAA downstream primer specific for IHHNV isothermal amplification is IHHNV-RAA-R1, and the nucleotide sequence is shown in SEQ ID NO: 4; The nucleotide sequence of the crRNA against IHHNV is shown in SEQ ID NO: 6; and reporter probe sequences; The reporter probe sequence is a single-stranded DNA reporter probe sequence for fluorescence detection and a single-stranded DNA reporter probe sequence for immunocolloidal gold test strip detection; The single-stranded DNA reporter probe sequence used for fluorescence detection, the specific nucleotide sequence P1 is 5,-FAM-TTATT-BHQ1 -3; The single-stranded DNA reporter probe sequence used for immune colloidal gold test strip detection, the specific nucleotide sequence P2 is 5, -FAM-TTTTTTTTTTTTTTTTTTTT-BIOTIN-3.

2. A kit for visual detection of IHHNV based on CRISPR / Cas 12a, It is characterized in that The kit comprises the isothermal amplification-specific RAA primers and crRNA sequences and single-stranded DNA reporter probe sequences for IHHNV according to claim 1.

3. The kit according to claim 2, It is characterized in that The kit includes reaction reagents for RAA amplification reaction and reagents for performing CRISPR / Cas 12a reaction.

4. The kit according to claim 3, It is characterized in that The total volume of the reaction reagents for RAA amplification is 50uL, and the reaction reagents include dry powder enzyme preparation, water, RAA upstream primer IHHNV F2, RAA downstream primer IHHNV-RAA-R1, A Buffer, B Buffer and DNA nucleic acid to be detected.

5. The kit according to claim 3, It is characterized in that The total volume of the reagents for the CRISPR / Cas 12a reaction is 50uL, and the reaction reagents include reagents for the CRISPR / Cas 12a reaction for fluorescence detection and reagents for the CRISPR / Cas 12a reaction for immunocolloidal gold test strip detection; The reagents for the CRISPR / Cas 12a reaction for fluorescence detection include Cas12a enzyme, IHHNV-crRNA, reaction buffer, single-stranded DNA reporter probe-P1 for fluorescence detection, ddH2O, and specific RAA products to be detected.

6. The kit according to claim 5, It is characterized in that The reagents for the CRISPR / Cas 12a reaction for immunocolloidal gold test strip detection include Cas12a enzyme, IHHNV-crRNA, reaction buffer, single-stranded DNA reporter probe-P2 for immunocolloidal gold test strip detection, ddH2O, and specific RAA products to be detected.

7. A method for visual detection of IHHNV based on CRISPR / Cas 12a, It is characterized in that The following steps are involved: Step 1): Sample processing: take the shrimp muscle tissue, cut it into pieces and centrifuge it; Step 2): Extracting nucleic acid from shrimp muscle tissue; Step 3): RAA amplification reaction; Step 4): Using the kit of any one of claims 2 to 6, take the RAA amplification primer and perform CRISPR / Cas 12a reaction reagent for fluorescence detection or immunocolloidal gold test strip detection.

8. A method for visual detection of IHHNV based on CRISPR / Cas 12a, It is characterized in that The following steps are involved: Step 1-1): Sample processing: take about 50 mg of shrimp muscle tissue, chop it with scissors and place it in a 2 mL centrifuge tube, add steel balls and 1 mL of 1 mol / L PBS, shake it with a homogenizer, centrifuge it at 12000 rpm for 2 minutes, and use the supernatant for nucleic acid extraction; Step 2-2): Nucleic acid extraction: ABI commercial kit is used for nucleic acid extraction, genomic DNA is extracted according to the instructions, and the extracted nucleic acid is used as a template for RAA amplification; Step 3-3): RAA amplification reaction, the total volume of the amplification reaction reagent is 50 uL, first add 25 μL A Buffer, 2 uL RAA upstream primer IHHNV F2 / R1, 2 uL RAA downstream primer IHHNV-RAA-R1, 13.5 uL water to the detection unit tube containing the dry powder enzyme preparation, and then add 5 uL of DNA nucleic acid to be tested to the detection unit tube; add 2.5 uL B Buffer to the detection unit tube cover, cover the tube cover, turn it upside down and shake it gently to mix thoroughly, and then centrifuge it at low speed for 10 sec; Place the centrifuged detection unit tube in a 39°C constant temperature metal bath or water bath and incubate for 30 minutes; Step 4-4): The total volume of reagents used for CRISPR / Cas 12a reaction is 50uL; The reaction reagents include: adding 0.5 μL of Cas12a enzyme, 0.2 uL of IHHNV-crRNA, 5 μL of 10×reaction buffer, 2 uL of single-stranded DNA reporter probe for fluorescence detection--P1, 40.3 uL of ddH2O, and 2 uL of specific RAA product to be detected into a PCR tube, covering the tube with a cap, vortexing evenly, and then centrifuging at low speed for 10 s for CRISPR / Cas 12a fluorescence detection; The fluorescence PCR instrument was set to a reaction temperature of 37°C and the fluorescence value was read every 1 min for 45 min; The reaction reagent includes: adding Cas12a (2 μM) 0.5 μL and IHHNV-crRNA 0.2 μL, 10× reaction buffer 5 μL, single-stranded DNA reporter probe-P22uL of colloidal gold test strip, ddH2O40.3 uL, and specific RAA product to be detected 2uL in a PCR tube, covering the tube cap, vortexing evenly, and then centrifuging at low speed for 10 s, to prepare a reagent for CRISPR / Cas 12a reaction detected by immunocolloidal gold test strip; The reaction tube was incubated at 37°C for 30 min. After the incubation, the colloidal gold test strip was added to read the result.

9. Use of the kit according to any one of claims 2 to 7 in detecting IHHNV.

10. Application of the method for visually detecting IHHNV based on CRISPR / Cas 12a according to claim 7 or 8 in detecting IHHNV.